CLINICAL_TRIALS
research
· 2024-11-01
Clinical Trial Update: The DRAGON 2 Trial [NA]
Summary
The DRAGON 2 trial, sponsored by Maastricht University, is currently recruiting for colorectal cancer with liver metastases, focusing on small future liver remn…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Maastricht University | Conditions: Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR) | NA | Status: RECRUITING